Thorac Cardiovasc Surg 2014; 62(01): 035-041
DOI: 10.1055/s-0033-1348919
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Results of Modern Mitral Valve Repair in Patients with Marfan Syndrome

Alexander Martin Bernhardt
1   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
*   Both authors contributed equally to this manuscript.
,
Hendrik Treede
1   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
*   Both authors contributed equally to this manuscript.
,
Christian Detter
1   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Meike Rybczynski
2   Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Sara Sheikhzadeh
2   Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Florian Mathias Wagner
1   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
,
Yskert Von Kodolitsch
2   Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
,
Hermann Reichenspurner
1   Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

08 February 2013

21 May 2013

Publication Date:
09 July 2013 (online)

Abstract

Objectives Mitral valve (MV) regurgitation is a common manifestation in patients with Marfan syndrome (MFS) and is age dependent. Valve pathology shares some features with myxomatous MV disease. Surgical treatment is still being debated and not well characterized in patients with MFS.

Patients and Methods We retrospectively evaluated the results of mitral valve repair (MVR) of symptomatic patients with MFS who underwent surgery between January 2004 and April 2011. MFS was diagnosed following the Ghent criteria. MVR was performed in 12 patients. Three patients underwent minimally invasive MVR despite severe thorax deformities. Mean follow-up was 60.1 months (95% CI: 48–72) and was complete.

Results Thirty-day mortality was 0%. One patient died because of arrhythmia 66 months after MVR. Transthoracic echocardiography at last visit showed mild mitral regurgitation in one patient (8.3%) and no mitral regurgitation in the remaining patients (91.7%).

Conclusion MVR was associated with excellent survival and a low rate of complications. Transthoracic echocardiography showed good results of the repaired valves even years later. Minimally invasive repairs are feasible even in deformed thoraces, lowering the risk for future aortic surgery. Because of excellent mid-term to long-term results, MVR may also be justified in asymptomatic Marfan patients.

 
  • References

  • 1 Silverman DI, Burton KJ, Gray J , et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75 (2) 157-160
  • 2 Rybczynski M, Bernhardt AM, Rehder U , et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet A 2008; 146A (24) 3157-3166
  • 3 Rybczynski M, Treede H, Sheikhzadeh S , et al. Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome. Am J Cardiol 2011; 107 (2) 268-274
  • 4 Taub CC, Stoler JM, Perez-Sanz T , et al. Mitral valve prolapse in Marfan syndrome: an old topic revisited. Echocardiography 2009; 26 (4) 357-364
  • 5 Bhudia SK, Troughton R, Lam BK , et al. Mitral valve surgery in the adult Marfan syndrome patient. Ann Thorac Surg 2006; 81 (3) 843-848
  • 6 Fleischer KJ, Nousari HC, Anhalt GJ, Stone CD, Laschinger JC. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome. Ann Thorac Surg 1997; 63 (4) 1012-1017
  • 7 De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62 (4) 417-426
  • 8 Rybczynski M, Mir TS, Sheikhzadeh S , et al. Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol 2010; 106 (7) 1048-1053
  • 9 Carpentier A. Cardiac valve surgery—the “French correction”. J Thorac Cardiovasc Surg 1983; 86 (3) 323-337
  • 10 Carpentier A, Chauvaud S, Fabiani JN , et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg 1980; 79 (3) 338-348
  • 11 Carpentier A, Deloche A, Dauptain J , et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg 1971; 61 (1) 1-13
  • 12 Perier P, Hohenberger W, Lakew F , et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the “respect rather than resect” approach. Ann Thorac Surg 2008; 86 (3) 718-725 ; discussion 718–725
  • 13 van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001; 84 (2) 129-137
  • 14 De Backer J, Loeys B, Devos D, Dietz H, De Sutter J, De Paepe A. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genet Med 2006; 8 (7) 401-408
  • 15 Rand-Hendriksen S, Lundby R, Tjeldhorn L , et al. Prevalence data on all Ghent features in a cross-sectional study of 87 adults with proven Marfan syndrome. Eur J Hum Genet 2009; 17 (10) 1222-1230
  • 16 Freed LA, Levy D, Levine RA , et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341 (1) 1-7
  • 17 Bonow RO, Carabello BA, Chatterjee K , et al; 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118 (15) e523-e661
  • 18 Braunberger E, Deloche A, Berrebi A , et al. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 2001; 104 (12) (Suppl. 01) I8-I11
  • 19 Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 2010; 31 (16) 1958-1966
  • 20 Falk V, Seeburger J, Czesla M , et al. How does the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial. J Thorac Cardiovasc Surg 2008; 136 (5) 1205 , discussion 1205–1206
  • 21 Seeburger J, Kuntze T, Mohr FW. Gore-tex chordoplasty in degenerative mitral valve repair. Semin Thorac Cardiovasc Surg 2007; 19 (2) 111-115
  • 22 Risteski PS, Aybek T, Dzemali O , et al. Artificial chordae for mitral valve repair: mid-term clinical and echocardiographic results. Thorac Cardiovasc Surg 2007; 55 (4) 239-244
  • 23 Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995; 91 (4) 1022-1028
  • 24 McCarthy PM. When is your surgeon good enough? When do you need a “referent surgeon”?. Curr Cardiol Rep 2009; 11 (2) 107-113
  • 25 David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg 2005; 130 (5) 1242-1249
  • 26 Fuzellier JF, Chauvaud SM, Fornes P , et al. Surgical management of mitral regurgitation associated with Marfan's syndrome. Ann Thorac Surg 1998; 66 (1) 68-72
  • 27 Gillinov AM, Hulyalkar A, Cameron DE , et al. Mitral valve operation in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 1994; 107 (3) 724-731
  • 28 Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove DM. Mechanism of outflow tract obstruction causing failed mitral valve repair. Anterior displacement of leaflet coaptation. Circulation 1993; 88 (5 Pt 2) II24-II29
  • 29 Mihaileanu S, Marino JP, Chauvaud S , et al. Left ventricular outflow obstruction after mitral valve repair (Carpentier's technique). Proposed mechanisms of disease. Circulation 1988; 78 (3 Pt 2) I78-I84
  • 30 Kronzon I, Cohen ML, Winer HE, Colvin SB. Left ventricular outflow obstruction: a complication of mitral valvuloplasty. J Am Coll Cardiol 1984; 4 (4) 825-828
  • 31 Kreindel MS, Schiavone WA, Lever HM, Cosgrove D. Systolic anterior motion of the mitral valve after Carpentier ring valvuloplasty for mitral valve prolapse. Am J Cardiol 1986; 57 (6) 408-412
  • 32 Stewart WJ, Currie PJ, Salcedo EE , et al. Intraoperative Doppler color flow mapping for decision-making in valve repair for mitral regurgitation. Technique and results in 100 patients. Circulation 1990; 81 (2) 556-566
  • 33 Shah PM, Raney AA. Echocardiographic correlates of left ventricular outflow obstruction and systolic anterior motion following mitral valve repair. J Heart Valve Dis 2001; 10 (3) 302-306
  • 34 Maslow AD, Regan MM, Haering JM, Johnson RG, Levine RA. Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease. J Am Coll Cardiol 1999; 34 (7) 2096-2104
  • 35 Manabe S, Kasegawa H, Fukui T, Tabata M, Shimokawa T, Takanashi S. Morphological analysis of systolic anterior motion after mitral valve repair. Interact Cardiovasc Thorac Surg 2012; 15 (2) 235-239
  • 36 Carpentier A. The sliding leaflet technique. Club Mitrale Newslett 1988; 2-3
  • 37 Mesana T, Ibrahim M, Hynes M. A technique for annular plication to facilitate sliding plasty after extensive mitral valve posterior leaflet resection. Ann Thorac Surg 2005; 79 (2) 720-722